Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nihon Chouzai Co ( (JP:3341) ) has provided an update.
Nihon Chouzai Co., Ltd. has announced a change in its representative directors to strengthen its management and increase corporate value. Kazunori Ogi will take over as President and Representative Director, succeeding Naoto Kasai. This leadership change is part of the company’s strategy for medium- to long-term growth and continued contribution to the healthcare sector in Japan.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the healthcare industry, focusing on providing pharmaceutical services and products. The company aims to support healthcare in Japan and is committed to expanding its business under a new management structure.
Average Trading Volume: 306,922
Technical Sentiment Signal: Buy
Current Market Cap: Yen86.5B
See more insights into 3341 stock on TipRanks’ Stock Analysis page.